Public Companies

Prelude Therapeutics raises $25M in share sale

Prelude Therapeutics, a cancer drug development firm, closed a $25 million share sale Wednesday that will help extend its funding runway.

Famed former DuPont CEO Woolard dies at 89

Edgar "Ed" S. Woolard Jr., the former CEO and chair of DuPont and chair of Apple who led the companies through tremendous change, died Monday.

Ashland to explore Nutraceuticals sale amid reduced revenue

Ashland is planning to sell its Nutraceuticals business segment and invest in other core segments as its consolidates its portfolio.

CRISP developer secures $63M in new financing

MRA Group, the developer behind the Chestnut Run Innovation and Science Park (CRISP), has secured $63 million in financing for the project.
- Advertisement -

Artesian to raise nearly $35M in share sale

NEWARK – Artesian Resources, the water and wastewater utility company, expects to raise $34.8 million in a...

Prelude Therapeutics to raise $100M in share sale

Prelude Therapeutics announced Thursday that it’s selling millions of new shares to raise $100 million to support its drug pipeline research.

InterDigital inks licensing deals, raises share buybacks

WILMINGTON – InterDigital, the mobile and video technology research and development company, signed two technology licensing deals...

Chemours board member resigns over abortion, trans benefits

WILMINGTON – A longtime board of directors’ member for Chemours has resigned in dispute with leadership of...
- Advertisement -

Delaware employers begin severing Russian ties

More than two months after the war in Ukraine began, many of the multinational companies that have...

Incyte signs Japanese deal for eczema cream

WILMINGTON – Incyte announced recently that it has signed a deal with a Japanese dermatological product maker...

Current Issue

What's New

More Business News ...

Digital Partners

Important information for subscribers accessing "Insider" content

Close the CTA